A groundbreaking study presented at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting has raised concerns about the safety of popular weight-loss medications, revealing they may elevate the risk of fractures and gout by up to 30%. The findings highlight potential health risks associated with GLP-1 receptor drugs such as Ozempic, Wegovy, and their Indian generic equivalents, widely used for weight management and diabetes control.
The extensive research tracked over 146,000 patients over five years, comparing users of these drugs with those employing other weight-loss methods. Results showed a significant increase in bone-related issues and gout among drug users:
- A 30% higher risk of osteoporosis, a condition where bones become porous and prone to fractures.
- A 12% rise in gout, a painful inflammatory arthritis caused by uric acid crystal buildup in joints.
- A doubling of the risk of osteomalacia, a condition characterized by softening of bones due to vitamin D deficiency.
These statistics are particularly concerning for India, where vitamin D deficiency affects nearly 70-80% of the population, and where the surge in GLP-1 use is coinciding with a country already vulnerable to bone health issues.
Experts explain that rapid weight loss can make bones brittle by reducing the load they typically support, prompting the body to reabsorb bone minerals. Furthermore, the appetite-suppressing effects of these drugs can lead to deficiencies in essential nutrients like calcium, magnesium, and protein, further weakening bones. Additionally, rapid fat loss may increase ketone production, interfering with kidney function and leading to elevated uric acid levels, which can trigger gout attacks.
In India’s context, these risks are compounded by lower baseline bone mineral density and dietary factors such as vegetarianism, which often results in lower protein intake. This combination increases the danger of developing “skinny fat,” where weight loss leads to loss of muscle and bone mass, raising the risk of falls, fractures, and long-term health complications.
Health authorities and experts advise caution for individuals using or considering weight-loss drugs, emphasizing the importance of balanced nutrition and monitoring bone health. As weight management continues to be a global focus, understanding these risks is crucial to ensuring safe and sustainable health strategies.